Furthermore, polymorphisms in the IL-1β, TNF-α, and C-reactive protein may increase the risk of depression, and single nucleotide polymorphisms (SNP) in the IL-1β, IL-6, and IL-11 genes may be associated with decreased efficacy of anti-depressant treatment [47,48]. This evidence concerns the gene IL1B and depressive symptom measurement.